Year: 2026
Type: article
Abstract: The spleen is one of the key organs of the immune system that is involved in both innate and adaptive immunity. Splenectomy (SE) is surgery with many risks, including sepsis, thrombosis, and malignancy. In this regard, studies into the potential regeneration of the spleen and restoring its structure and functions are important. As in the past, heterotopic spleen transplantation regenerates the spleen structure after 30 days. This study assessed the impact of heterotopic spleen regeneration on tumor growth. We used two animal models. In the first, animals had SE. In the second, animals had SE and subcutaneous transplantation (ST) of spleen fragments. These animals, as well as intact animals, were transplanted under the skin with tumor cells to obtain a subcutaneous model of tumor growth. The results showed that while there was no significant effect on tumor growth at 15 days, there was a decrease in tumor cell proliferation rate. Spleen regeneration stimulated early occupancy of the tumor niche by macrophages, as well as influx of CD4+ T-lymphocytes and B-lymphocytes into the tumor, while infiltration of CD8+ T-lymphocytes was suppressed. Thus, the effects of regenerating spleen on tumor growth that we have demonstrated require further investigation at longer follow-up periods.
Source: FASEB BioAdvances
Authors: Daria Artemova, Andrey Elchaninov, Anna Soboleva, Irina Arutyunyan, Polina Vishnyakova, Liudmila Gaydeek, Timur Fatkhudinov, Gennady Sukhikh
Institutions: Peoples' Friendship University of Russia, Research Institute of Human Morphology, Russian Scientific Center of Surgery, National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of the Russian Federation
Language: English
Topic: Immune cells in cancer
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,880
Funder: Russian Science Foundation
Award: G411963806
OpenAlex ID: W7119484176
